| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 29.735 | 7.687 | 525 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 29.736 | 7.743 | 1.210 |
| Total Expenses - EUR | - | - | - | - | - | - | 6 | 17.253 | 9.886 | 8.745 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -6 | 12.483 | -2.143 | -7.535 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -6 | 12.165 | -2.208 | -7.535 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Skino Pharm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 40 | 12.209 | 16.967 | 13.823 |
| Inventories | - | - | - | - | - | - | 0 | 7.178 | 13.796 | 13.719 |
| Receivables | - | - | - | - | - | - | 0 | 2.190 | 205 | 81 |
| Cash | - | - | - | - | - | - | 40 | 2.841 | 2.966 | 23 |
| Shareholders Funds | - | - | - | - | - | - | 34 | 12.200 | 9.955 | 2.364 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 6 | 1.349 | 7.012 | 11.459 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
2042
|
|||||||||
Comments - Skino Pharm S.r.l.